Gerstmann-Sträussler-Scheinker disease (GSS) ischaracterized by the accumulation of proteinase K (PK)-resistant prion protein fragments (PrP sc ) of ϳ7 to 15 kd in the brain. Purified GSS amyloid is composed primarily of ϳ7-kd PrP peptides, whose N terminus corresponds to residues W 81 and G 88 to G 90 in patients with the A117V mutation and to residue W 81 in patients with the F198S mutation. The aim of this study was to characterize PrP in brain extracts, microsomal preparations, and purified fractions from A117V patients and to determine the N terminus of PrP sc species in both GSS A117V and F198S. In all GSS A117V patients, the ϳ7-kd PrP sc fragment isolated from nondigested and PK-digested samples had the major N terminus at residue G 88 and G 90 , respectively. Conversely, in all patients with GSS F198S, an ϳ8-kd Prion diseases are neurodegenerative disorders present in both humans and animals.